{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T07:57:46Z","timestamp":1722931066156},"reference-count":16,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T00:00:00Z","timestamp":1251244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p> <jats:italic>\n            <jats:bold>Background:<\/jats:bold> Cardiac resynchronization therapy (CRT) has proven to be a valuable therapy addition for patients with drug\u2010refractory heart failure and a ventricular conduction delay. Delivery of CRT is dependent upon the successful implantation and chronic performance of a left ventricular (LV) pacing lead. This study assessed the long\u2010term electrical performance and safety of a steroid\u2010eluting, transvenous, over\u2010the\u2010wire, cardiac vein pacing lead.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Methods:<\/jats:bold> The Attain Model 4193 LV lead (Medtronic, Inc, Minneapolis MN, USA) was successfully implanted in 1,070 patients with 286 patients completing 3 years of follow\u2010up. Clinical data were collected at pre\u2010implant, implant, and at 6\u2010month intervals for 3 years.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Results:<\/jats:bold> Over 3 years, the mean chronic pacing threshold ranged from 1.9 V to 2.1 V, the mean R\u2010wave sensing amplitudes ranged between 13.6 mV and 15.0 mV, and the mean pacing impedance ranged between 562 ohms and 590 ohms. Additionally, the observed freedom from first post\u2010implant LV\u2010lead\u2010related complications was 90.4%. Of 1,070 total patients, 82 experienced 89 LV\u2010lead\u2010related adverse events requiring invasive interventions or resulting in the termination of the CRT therapy. The LV lead was repositioned in 31 patients, replaced in 21 patients, and explanted\/capped in four patients. There were no deaths related to the LV lead during implantation or during the follow\u2010up period.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Conclusions:<\/jats:bold> The data suggest that the 4193 LV lead is safe and effective over time. The LV lead electrical measurements remained stable through follow\u2010up, demonstrating reliable long\u2010term performance within the recommended value range at 36 months and had an acceptable complication rate.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2009.02451.x","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T17:16:00Z","timestamp":1251306960000},"page":"1111-1116","source":"Crossref","is-referenced-by-count":7,"title":["Long\u2010Term Performance of the Attain Model 4193 Left Ventricular Lead"],"prefix":"10.1111","volume":"32","author":[{"given":"W. BEN","family":"JOHNSON","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"WILLIAM T.","family":"ABRAHAM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JAMES B.","family":"YOUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KEVIN","family":"WHEELAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREW L.","family":"SMITH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YANPING","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAULA","family":"BRINKMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the InSync Registry Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,26]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013168"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032423"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl099"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2004.00693.x"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1025312319011"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.20.2685"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2002.01183.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013168"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.031"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.08.032"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1053\/eupc.2002.0288"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2006.00327.x"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2005.04600.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.86.4.405"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.09548.x"},{"issue":"1","key":"e_1_2_8_17_2","first-page":"53","article-title":"Cardiac resynchronization therapy: Implantation tips and tricks","volume":"7","author":"Hasdemir C","year":"2007","journal-title":"Anadolu Kardiyol Derg"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2009.02451.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2009.02451.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T11:34:21Z","timestamp":1697283261000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2009.02451.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,26]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1540-8159.2009.02451.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2009.02451.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"type":"print","value":"0147-8389"},{"type":"electronic","value":"1540-8159"}],"subject":[],"published":{"date-parts":[[2009,8,26]]}}}